Artículos de revistas
Evolution Of Performance Status, Body Mass Index, And Six-minute Walk Distance In Advanced Lung Cancer Patients Undergoing Chemotherapy [evolução Do Status De Performance, índice De Massa Corpórea E Distância Percorrida No Teste De Caminhada De Seis Minutos Em Pacientes Com Câncer De Pulmão Avançado Submetidos à Quimioterapia]
Registro en:
Jornal Brasileiro De Pneumologia. , v. 36, n. 5, p. 588 - 594, 2010.
18063713
2-s2.0-78649414946
Autor
Machado L.
Saad I.A.B.
Honma H.N.
Morcillo A.M.
Zambon L.
Institución
Resumen
Objective: To evaluate the effect of chemotherapy on the physical condition of patients with advanced lung cancer. Methods: We evaluated 50 patients with non-small cell lung cancer (in stages IIIB and IV) and Eastern Cooperative Oncology Group (ECOG) performance status scale scores between zero and two. All patients underwent chemotherapy using paclitaxel and platinum derivatives and were evaluated at three time points (prechemotherapy, postchemotherapy and six months after starting the treatment), at which the ECOG scale, the body mass index (BMI) and the six-minute walk distance (6MWD) were assessed. Results: Of the 50 patients included in the study, 14 died, 5 were excluded due to the worsening of their performance status, and 31 completed the six-month follow-up. There was no statistically significant difference between the time points of assessment for BMI (prechemotherapy vs. postchemotherapy, p = 1.00; and prechemotherapy vs. six months later, p = 0.218) or for 6MWD. Performance status improved, and this was especially due to the increase in the number of asymptomatic patients after the six-month follow-up (p = 0.031). Conclusions: Chemotherapy had a beneficial effect on the performance status of the patients. No significant changes in BMI or 6MWD were found during the study period, which might suggest the maintenance of the physical condition of the patients. 36 5 588 594 (2008) Incidência De Câncer No Brasil, p. 2007. , Instituto Nacional de Câncer. Estimativas, Rio de Janeiro: INCA Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., Cancer statistics, 2008 (2008) CA Cancer J Clin, 58 (2), pp. 71-96 Novaes, F.T., Cataneo, D.C., Ruiz, J.R.L., Defaveri, J., Michelin, O.C., Cataneo, A.J., Lung cancer: Histology, staging, treatment and survival (2008) J Bras Pneumol, 34 (8), pp. 595-600 Barros, J.A., Valladares, G., Faria, A.R., Fugita, E.M., Ruiz, A.P., Vianna, A.G., Early diagnosis of lung cancer: The great challenge (2006) J Bras Pneumol, 32 (3), pp. 221-227. , Epidemiological variables, clinical variables, staging and treatment Mohan, A., Singh, P., Singh, S., Goyal, A., Pathak, A., Mohan, C., Quality of life in lung cancer patients: Impact of baseline clinical profile and respiratory status (2007) Eur J Cancer Care (Engl), 16 (3), pp. 268-276 Corner, J., Hopkinson, J., Fitzsimmons, D., Barclay, S., Muers, M., Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis (2005) Thorax, 60 (4), pp. 314-319 Schiller, J.H., Harrington, D., Belani, C.P., Langer, C., Sandler, A., Krook, J., Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer (2002) N Engl J Med, 346 (2), pp. 92-98 Ferreira, K.A., Kimura, M., Teixeira, M.J., Mendoza, T.R., da Nóbrega, J.C., Graziani, S.R., Impact of cancer-related symptom synergisms on health-related quality of life and performance status (2008) J Pain Symptom Manage, 35 (6), pp. 604-616 Adamsen, L., Midtgaard, J., Rorth, M., Borregaard, N., Andersen, C., Quist, M., Feasibility, physical capacity, and health benefits of a multidimensional exercise program for cancer patients undergoing chemotherapy (2003) Support Care Cancer, 11 (11), pp. 707-716 Brown, P., Clark, M.M., Atherton, P., Huschka, M., Sloan, J.A., Gamble, G., Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer? (2006) Am J Clin Oncol, 29 (1), pp. 52-58 Franceschini, J., Santos, A.A., El, M.I., Jamnik, S., Uehara, C., Fernandes, A.L., Assessment of the quality of life of patients with lung cancer using the Medical Outcomes Study 36-item Short-Form Health Survey (2008) J Bras Pneumol, 34 (6), pp. 387-393 Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Toxicity and response criteria of the Eastern Cooperative Oncology Group (1982) Am J Clin Oncol, 5 (6), pp. 649-655 de Onis, M., Habicht, J.P., Anthropometric reference data for international use: Recommendations from a World Health Organization Expert Committee (1996) Am J Clin Nutr, 64 (4), pp. 650-658 ATS statement: Guidelines for the six-minute walk test (2002) Am J Respir Crit Care Med, 166 (1), pp. 111-117. , ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories Zar, J.H., (1999) Biostatistical Analysis, p. 663. , Upper Saddle River: Prentice Hall Conover, W.J., (1999) Practical Nonparametric Statistics, p. 586. , New York: Wiley Anelli, A., Lima, C.A., Younes, R.N., Gross, J.L., Fogarolli, R., Chemotherapy versus best supportive care in stage IV non-small cell lung cancer, non metastatic to the brain (2001) Rev Hosp Clin Fac Med Sao Paulo, 56 (2), pp. 53-58 Vardy, J., Dadasovich, R., Beale, P., Boyer, M., Clarke, S.J., Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials (2009) BMC Cancer, 9, p. 130 Paesmans, M., Benefits of chemotherapy for quality of life in patients with advanced nonsmall-cell lung cancer (2002) Curr Opin Oncol, 14 (4), pp. 389-393 Brearley, S.G., Clements, C.V., Molassiotis, A., A review of patient self-report tools for chemotherapy-induced nausea and vomiting (2008) Support Care Cancer, 16 (11), pp. 1213-1229 Wang, X.S., Fairclough, D.L., Liao, Z., Komaki, R., Chang, J.Y., Mobley, G.M., Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms (2006) J Clin Oncol, 24 (27), pp. 4485-4491 Spiro, S.G., Porter, J.C., Lung cancer--where are we today? Current advances in staging and nonsurgical treatment (2002) Am J Respir Crit Care Med, 166 (9), pp. 1166-1196 Di, M.M., Perrone, F., Quality of life in elderly patients with cancer (2003) Health Qual Life Outcomes, 1, p. 44 Lheureux, M., Raherison, C., Vernejoux, J.M., Nguyen, L., Nocent, C., de Tunon, L.M., Quality of life in lung cancer: Does disclosure of the diagnosis have an impact? (2004) Lung Cancer, 43 (2), pp. 175-182 Lamont, E.B., Christakis, N.A., Complexities in prognostication in advanced cancer: To help them live their lives the way they want to (2003) JAMA, 290 (1), pp. 98-104 Mohan, A., Singh, P., Kumar, S., Mohan, C., Pathak, A.K., Pandey, R.M., Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer (2008) Asian Pac J Cancer Prev, 9 (4), pp. 557-562 Kasymjanova, G., Correa, J.A., Kreisman, H., Dajczman, E., Pepe, C., Dobson, S., Prognostic value of the six-minute walk in advanced non-small cell lung cancer (2009) J Thorac Oncol, 4 (5), pp. 602-607